跳至主要内容
临床试验/NCT03455751
NCT03455751终止不适用

Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery

The Cleveland Clinic1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2018年4月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
10
试验地点
1
主要终点
Post-operative opioid use

研究概览

简要总结

The primary objectives of this study are to evaluate the potential for preoperative pharmacogenomics (PGx) testing to positively influence postoperative opioid use through visual analog scale (VAS) guided administration of narcotic equivalent and lower pain scores as measured by OBAS in patients undergoing major abdominal surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Subject capable of giving consent
  • •Age 18-80
  • •Scheduled for open colorectal resection at Cleveland Clinic main campus (with preoperative appointment scheduled at least five days before date of surgery)

排除标准

  • •Patient does not speak English
  • •Patient with substance-use disorder (including alcohol)
  • •Patient diagnosed with major depression
  • •Patient currently taking opioids
  • •Previous long-term opioid use (> 3 months)
  • •Previous opioid use with a dose of >100 milligram morphine equivalent (MME)
  • •Patient has pain-related disorder (e.g. fibromyalgia, sympathetic dystrophy, etc.)
  • •Documented allergy to pain medication

研究组 & 干预措施

Control

No Intervention

The control arm will receive no intervention and will follow standard of care for post-operative pain management.

PGx-guided

Experimental

The PGx-guided arm will received altered post-operative pain management based on the results of pharmacogenomic testing.

干预措施: PGx-guided post-operative pain management (Genetic)

结局指标

主要结局

Post-operative opioid use

时间窗: Post-op day 1

Post-operative opioid use through visual analog scale guided administration of narcotic equivalent

Overall Benefit of Analgesia Score (OBAS)

时间窗: Post-op day 1

次要结局

  • Length of stay(30 days)
  • Readmission rate(30 days)
  • Functional status(4 weeks and 3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Liska

Associate Staff, Colorectal Surgery

The Cleveland Clinic

研究点 (1)

Loading locations...

相似试验